0001752724-24-020875.txt : 20240208
0001752724-24-020875.hdr.sgml : 20240208
20240208124117
ACCESSION NUMBER: 0001752724-24-020875
CONFORMED SUBMISSION TYPE: N-CEN
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20231130
FILED AS OF DATE: 20240208
DATE AS OF CHANGE: 20240208
EFFECTIVENESS DATE: 20240208
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: MFS SERIES TRUST II
CENTRAL INDEX KEY: 0000798250
ORGANIZATION NAME:
IRS NUMBER: 000000000
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1130
FILING VALUES:
FORM TYPE: N-CEN
SEC ACT: 1940 Act
SEC FILE NUMBER: 811-04775
FILM NUMBER: 24607949
BUSINESS ADDRESS:
STREET 1: 111 HUNTINGTON AVENUE
STREET 2: 21ST FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02199
BUSINESS PHONE: 18006372929
MAIL ADDRESS:
STREET 1: 111 HUNTINGTON AVENUE
STREET 2: 21ST FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02199
FORMER COMPANY:
FORMER CONFORMED NAME: MFS SERIES TRUST II /MA/
DATE OF NAME CHANGE: 19940131
FORMER COMPANY:
FORMER CONFORMED NAME: MFS LIFETIME EMERGING GROWTH FUND
DATE OF NAME CHANGE: 19930408
FORMER COMPANY:
FORMER CONFORMED NAME: LIFETIME EMERGING GROWTH TRUST
DATE OF NAME CHANGE: 19920703
0000798250
S000002419
MFS Growth Fund
C000006430
A
MFEGX
C000006431
R4
MFEJX
C000006435
B
MEGBX
C000006436
C
MFECX
C000006437
I
MFEIX
C000006439
R1
MFELX
C000006441
R2
MEGRX
C000006442
R3
MFEHX
C000102727
R6
MFEKX
N-CEN
1
primary_doc.xml
X0404
N-CEN
LIVE
0000798250
XXXXXXXX
811-04775
true
false
false
N-1A
true
MFS Series Trust II
811-04775
0000798250
549300W3GYF777J7J466
111 Huntington Avenue
Boston
02199
US-MA
US
617-954-5000
The Depository Trust Company
55 Water Street
New York
10041
12128551000
Central Clearinghouse
Massachusetts Financial Services Company
111 Huntington Avenue
Boston
02199
16179545000
Investment adviser
TerraNua U.S. Corp d.b.a. My Compliance Office
535 5th Avenue, 4th floor
New York
10017
18669512280
Personal Trading System
MFS Fund Distributors, Inc.
111 Huntington Avenue
Boston
02199
16179545000
Principal underwriter
Institutional Shareholder Services, Inc.
702 King Farm Boulevard Suite 400
Rockville
20850-4045
13015560500
Proxy voting administrator
Icertis
14711 NE 29th Place, Suite 100
Bellevue
98007
14258697649
Contract management system
SS&C Technologies
333 West 11th Street
Kansas City
64105
18164351000
Technology Vendor
Iron Mountain, Inc.
1 Federal Street
Boston
02110
18008994766
Storage Vendor
MFS Service Center, Inc.
111 Huntington Avenue
Boston
02199
16179545000
Transfer agent
Ropes & Gray
Prudential Tower 800 Boylston Street
Boston
02199-3600
16179517000
Counsel
Charles River Development
700 District Avenue
Burlington
01803
17812380099
Investment related records
JPMorgan Chase Bank N.A.
383 Madison Avenue
New York
10179
12122706000
Custodian
Micro Focus, LLC
4555 Great America Parkway Suite 400
Santa Clara
95054-1243
16502586827
Storage Vendor
N
N
N-1A
1
Y
Steven E. Buller
N/A
N
Maryanne L. Roepke
N/A
N
John A. Caroselli
N/A
N
James W. Kilman, Jr.
N/A
N
Clarence Otis, Jr.
N/A
N
Michael W. Roberge
N/A
Y
John P. Kavanaugh
N/A
N
Maureen R. Goldfarb
N/A
N
Peter D. Jones
N/A
N
Laurie J. Thomsen
N/A
N
Rosa E. Licea-Mailloux
N/A
111 Huntington Avenue
Boston
02199
XXXXXX
N
N
N
N
N
N
N
MFS FUND DISTRIBUTORS, INC.
8-45321
000031052
N/A
Y
N
DELOITTE & TOUCHE LLP
34
N/A
N
N
N
N
N
N
MFS Growth Fund
S000002419
K4ZYIH3WSXKUSPKIPM59
N
9
0
0
N/A
N
N
Y
N
N
JPMorgan Chase Bank N.A.
8I5DZWZKVSZI1NUHU748
N
N
Revenue sharing split
Cash collateral reinvestment fee
1717922.45000000
3495.63000000
Rule 12d1-4 (17 CFR 270.12d1-4)
Rule 12d1-1 (17 CFR 270.12d1-1)
Rule 18f-4 (17 CFR 270.18f-4)
Rule 32a-4 (17 CFR 270.32a-4)
Rule 22d-1 (17 CFR 270.22d-1)
Rule 18f-4(c)(4) (17CFR 270.18f-4(c)(4))
Rule 18f-4(f)(17 CFR 270.18f-4(f))
Rule 17a-7 (17 CFR 270.17a-7)
Y
Y
N
N
MASSACHUSETTS FINANCIAL SERVICES COMPANY
801-17352
000110045
1G3OSH3GLGJ7X1JC5I61
N
MFS SERVICE CENTER, INC.
84-1316
N/A
Y
N
N
IHS Markit
549300HLPTRASHS0E726
GB
N
Refinitiv U.S. Holdings Inc.
549300WQWDPFSMQ8I087
N
ICE Data Pricing & Reference Data, LLC
5493000NQ9LYLDBCTL34
N
N
JPMorgan Chase Bank, National Association
7H6GLXDRUGQFU57RNE97
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
J.P. Morgan SE
549300ZK53CNGEEI6A29
FR
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
N
MFS Service Center, Inc.
084-01316
SEC identifier
Y
N
N
MASSACHUSETTS FINANCIAL SERVICES
1G3OSH3GLGJ7X1JC5I61
Y
N
N
Merrill Lynch, Pierce, Fenner & Smith Inc.
8-07221
000007691
8NAV47T0Y26Q87Y0QP81
88343.96000000
Wells Fargo Securities, LLC
8-65876
000126292
VYVVCKR63DVZZN70PB21
69728.71000000
BofA Securities, Inc.
8-69787
000283942
549300HN4UKV1E2R3U73
316396.53000000
Jefferies LLC
8-15074
000002347
58PU97L1C0WSRCWADL48
178082.07000000
Morgan Stanley & Co. LLC
8-15869
000008209
9R7GPTSO7KV3UQJZQ078
86325.89000000
Goldman Sachs & Co. LLC
8-00129
000000361
FOR8UP27PHTHYVLBNG30
174013.39000000
BTIG, LLC
8-65473
000122225
549300GTG9PL6WO3EC51
208169.86000000
BMO Capital Markets Corp.
8-34344
000016686
RUC0QBLBRPRCU4W1NE59
184745.17000000
UBS Securities LLC
8-22651
000007654
T6FIZBDPKLYJKFCRVK44
69460.15000000
J.P. Morgan Securities LLC
8-35008
000000079
ZBUT11V806EZRVTWT807
139380.37000000
1849976.47000000
Citigroup Global Markets Inc.
8-08177
000007059
MBNUM2BPBDO7JBLYG310
772619.40000000
J.P. Morgan Securities LLC
8-35008
000000079
ZBUT11V806EZRVTWT807
92223340.71999999
State Street Global Markets, LLC
8-69862
000285852
549300FDEDF5ORXCMQ56
67956538.96999999
Healthcare of Ontario Pension Plan Trust Fund
N/A
N/A
KRVONIXV1JBEY6WQ6092
CA
9052827.12000000
Bank of New York Mellon Corp.
N/A
N/A
WFLLPEPC7FZXENRZV188
158189.40000000
170163515.61000001
Y
36553485972.00000000
Uncommitted
100000000.00000000
N
Uncommitted
200000000.00000000
N
Committed
1450000000.00000000
N
N
N
N
false
false
true
false
false
false
INTERNAL CONTROL RPT
2
NCEN_MFS_Series_Trust_II.txt
REPORT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM
To the Board of Trustees of MFS Series Trust II and the
Shareholders of MFS Growth Fund:
In planning and performing our audit of the financial
statements of MFS Growth Fund (the "Fund") (one of the
series of MFS Series Trust II) as of and for the year ended
November 30, 2023, in accordance with the standards of
the Public Company Accounting Oversight Board (United
States), we considered the Fund's internal control over
financial reporting, including controls over safeguarding
securities, as a basis for designing our auditing
procedures for the purpose of expressing our opinion on
the financial statements and to comply with the
requirements of Form N-CEN, but not for the purpose of
expressing an opinion on the effectiveness of the Fund's
internal control over financial reporting. Accordingly, we
express no such opinion.
The management of the Fund is responsible for
establishing and maintaining effective internal control
over financial reporting. In fulfilling this responsibility,
estimates and judgments by management are required to
assess the expected benefits and related costs of
controls. A fund's internal control over financial reporting
is a process designed to provide reasonable assurance
regarding the reliability of financial reporting and the
preparation of financial statements for external purposes
in accordance with generally accepted accounting
principles. A fund's internal control over financial
reporting includes those policies and procedures that (1)
pertain to the maintenance of records that, in reasonable
detail, accurately and fairly reflect the transactions and
dispositions of the assets of the fund; (2) provide
reasonable assurance that transactions are recorded as
necessary to permit preparation of financial statements in
accordance with generally accepted accounting principles,
and that receipts and expenditures of the fund are being
made only in accordance with authorizations of
management of the fund and trustees of the trust; and
(3) provide reasonable assurance regarding prevention or
timely detection of unauthorized acquisition, use, or
disposition of a fund's assets that could have a material
effect on the financial statements.
Because of its inherent limitations, internal control over
financial reporting may not prevent or detect
misstatements. Also, projections of any evaluation of
effectiveness to future periods are subject to the risk that
controls may become inadequate because of changes in
conditions or that the degree of compliance with the
policies or procedures may deteriorate.
A deficiency in internal control over financial reporting
exists when the design or operation of a control does not
allow management or employees, in the normal course of
performing their assigned functions, to prevent or detect
misstatements on a timely basis. A material weakness is a
deficiency, or a combination of deficiencies, in internal
control over financial reporting, such that there is a
reasonable possibility that a material misstatement of a
fund's annual or interim financial statements will not be
prevented or detected on a timely basis.
Our consideration of the Fund's internal control over
financial reporting was for the limited purpose described
in the first paragraph and would not necessarily disclose
all deficiencies in internal control that might be material
weaknesses under standards established by the Public
Company Accounting Oversight Board (United States).
However, we noted no deficiencies in the Fund's internal
control over financial reporting and its operations,
including controls for safeguarding securities, that we
consider to be a material weakness, as defined above, as
of November 30, 2023.
This report is intended solely for the information and use
of management, the Board of Trustees of MFS Series
Trust II and the Securities and Exchange Commission and
is not intended to be and should not be used by anyone
other than these specified parties.
/s/Deloitte & Touche LLP
Boston, Massachusetts
January 12, 2024